Search results
Showing 16 to 30 of 160 results for asthma
Digital platforms to support self-management of asthma : early value assessment
Awaiting development [GID-HTE10063] Expected publication date: TBC
Evidence-based recommendations on NIOX MINO, NIOX VERO and NObreath for measuring the amount of exhaled nitric oxide (FeNO) in the breath to help diagnose
Evidence-based recommendations on inhaled corticosteroids for treating chronic asthma in children under 12.
Evidence-based recommendations on inhaled corticosteroids for treating chronic asthma in adults and children aged 12 and over.
View recommendations for TA138Show all sections
Evidence-based recommendations on inhaler devices for routine treatment of chronic asthma in older children (aged 5 to 15 years).
NICE is unable to make a recommendation on SQ HDM SLIT (Acarizax) for treating allergic rhinitis and allergic asthma in adults caused by house dust mites. This is because ALK-Abello did not provide an evidence submission. We will review this decision if the company decides to make a submission.
Show all sections
Sections for TA834
Chronic obstructive pulmonary disease in over 16s: diagnosis and management (NG115)
This guideline covers diagnosing and managing chronic obstructive pulmonary disease or COPD (which includes emphysema and chronic bronchitis) in people aged 16 and older. It aims to help people with COPD to receive a diagnosis earlier so that they can benefit from treatments to reduce symptoms, improve quality of life and keep them healthy for longer.
In development [GID-TA11355] Expected publication date: 12 February 2025
Evidence-based recommendations on the use of inhaler systems (devices) for children under 5 years with chronic stable asthma.
NICE has developed a medtech innovation briefing (MIB) on Smartinhaler for asthma .
NICE has developed a medtech innovation briefing (MIB) on Smart Peak Flow for monitoring asthma .
NICE has developed a medtech innovation briefing (MIB) on Thora 3Di for assessing asthma in children .
This guideline covers assessing and managing food allergy in children and young people under 19. It aims to improve symptoms such as faltering growth and eczema by offering advice on how to identify food allergy and when to refer to secondary or specialist care.
Alair bronchial thermoplasty system for adults with severe difficult to control asthma (MIB71)
NICE has developed a medtech innovation briefing (MIB) on the Alair bronchial thermoplasty system for adults with severe, difficult to control asthma
Evidence-based recommendations on bronchial thermoplasty for severe asthma in adults. This involves applying heat to the inside walls of the airways.
View recommendations for IPG635Show all sections